Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Acquired Factor XIII Deficiency Is Associated with High Morbidity and Mortality in Critically Ill Patients

Miguel López Esteban, Marta Moreno Carbonell, Jesus Viñas Soler, Jose L. Diez Martin, Patricia Duque, Cristina Pascual Izquierdo

Blood (2022) 140 (Supplement 1): 1422–1424.

https://doi.org/10.1182/blood-2022-170330

Published: 2022

Journal Articles

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies

Joaquin Martinez Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Celina Benavente Cuesta, Lauren Benito, jose Angel Hernandez, Maria Regina Herraez, Pilar Herrera Puente, Mi Kwon, Keina Quiroz, Andres Arroyo, Adrian Alegre, María Pilar Llamas Sillero, Javier López Jiménez, Pedro Sanchez-Godoy, Rafael F. Duarte, Jose L. Diez Martin, Víctor Jiménez-Yuste, Julio Garcia-Suarez

Blood (2022) 140 (Supplement 1): 7924–7925.

https://doi.org/10.1182/blood-2022-169545

Published: 2022

Journal Articles

Dynamics and Management of CAR-T Cells Associated Cytopenias: A Single-Center Experience

Reyes María Martín-Rojas, Rebeca Bailen, Gillen Oarbeascoa, Mariana Bastos Oreiro, Ignacio Gómez-Centurión, Jon Badiola, Cristina Muñoz, Santiago Sabell, Javier Anguita, Jose L. Diez-Martin, Mi Kwon

Blood (2021) 138 (Supplement 1): 4837.

https://doi.org/10.1182/blood-2021-150975

Published: 2021

Journal Articles

Post-Transplant Cyclophosphamide after HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of Geth-TC

Blood (2021) 138 (Supplement 1): 3913.

https://doi.org/10.1182/blood-2021-150835

Published: 2021

Journal Articles

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Blood (2021) 138 (Supplement 1): 2607.

https://doi.org/10.1182/blood-2021-149147

Published: 2021

Journal Articles

Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia

Reyes María Martín-Rojas, Jon Badiola, Pablo Silva De Tena, Ana Pérez-Corral, Ignacio Gómez-Centurión, Gabriela Rodríguez-Macias, Mónica Ballesteros, Carolina Martínez-Laperche, Patricia Font Lopez, Isabel Pérez-Sánchez, Ismael Buño, Javier Anguita, Mi Kwon, Jose L. Diez-Martin

Blood (2021) 138 (Supplement 1): 1287.

https://doi.org/10.1182/blood-2021-150808

Published: 2021

Journal Articles

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience from the Spanish Group of Hematopoietic Transplant (GETH-TC)

Blood (2021) 138 (Supplement 1): 1798.

https://doi.org/10.1182/blood-2021-150992

Published: 2021

Journal Articles

Cell-Free DNA Dynamic Concentration, CRP and LDH Pre-Infusion Are Predictors of Early Progression after CAR T-Cell Therapy in DLBCL Patients

Mariana Bastos Oreiro, Laura Sanz-Villanueva, Francisco Diaz Crespo, Rebeca Bailén, Gillen Oarbeascoa, Isabel Gomez, Diego Carbonell, María Chicano Lavilla, Paula Muñiz, Javier Menarguez, Jose L. Diez-Martin, Mi Kwon, Ismael Buño, Carolina Martínez-Laperche

Blood (2021) 138 (Supplement 1): 1761.

https://doi.org/10.1182/blood-2021-144896

Published: 2021

Journal Articles

Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma in the Real World Setting in Spain

Blood (2021) 138 (Supplement 1): 1742.

https://doi.org/10.1182/blood-2021-147369

Published: 2021

Journal Articles

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Paola Alejandra Barzallo Burbano, Mar Meijón, Nuria Revilla Calvo, María Jesús Blanco Bañares, Begoña Fernández, Ramón Rodríguez-González, María Elena Sola Aparicio, Belén Rosado Sierra, Susana Asenjo Correa, Isabel Gutiérrez, María Pilar Llamas Sillero, José L. Díez-Martín, Gloria Pérez-Rus, Cristina Pascual Izquierdo

Blood (2021) 138 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2021-152962

Published: 2021

Journal Articles

Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation

Paula Muñiz Sevilla, Cristina Andres, Diego Carbonell, Mr, María Chicano Lavilla, PhD, Rebeca Bailen, Gillen Oarbeascoa, Julia Suárez González, Javier Anguita, MD PhD, Mi Kwon, Jose L. Diez-Martin, MD PhD, Carolina Martínez-Laperche, PhD, Ismael Buño

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136049

Published: 2020

Journal Articles

Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Reyes María Martín-Rojas, MD, Gillen Oarbeascoa, MD, Rebeca Bailén, MD, Ignacio Gómez-Centurión, MD, Luis Miguel Juarez, MD, Nieves Dorado, MD, Carolina Martínez-Laperche, PhD, Ana Pérez-Corral, MD PhD, Ismael Buño, PhD, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Mi Kwon, MDPhD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-141064

Published: 2020

Journal Articles

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Joshua A Fein, MD, Roni Shouval, MD PhD, Myriam Labopin, MD, Fabio Ciceri, MD, Emanuele Angelucci, MD, Didier Blaise, MD, Johanna Tischer, William Arcese, MD PhD, Yener Koc, MD, Benedetto Bruno, MD, Jose L. Diez-Martin, MD PhD, Stella Santarone, MD, Simona Sica, MD PhD, Jurjen Versluis, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139519

Published: 2020

Journal Articles

COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients

Reyes María Martín-Rojas, MD, Maite Chasco, MD, Sara Casanova, MD, Valeria Estefanía Delgado-Pinos, MD, Gloria Perez-Rus, MD PhD, Patricia Duque, MD, Milagros Sancho, MD, Jose L. Diez-Martin, MD PhD, Cristina Pascual Izquierdo, PhD MD

Blood (2020) 136 (Supplement 1): 5.

https://doi.org/10.1182/blood-2020-138882

Published: 2020

Journal Articles

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Very Severe Veno-Occlusive Disease after Unmanipulated Haploidentical HSCT with Post-Transplant Cyclophosphamide

Ignacio Gómez-Centurión, MD, Nieves Dorado, MD, Rebeca Bailén, MD, Miguel Echenagusia, MD, Arturo Alvarez, MD, Gillen Oarbeascoa, MD, Cristina Muñoz, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Mi Kwon, MD

Blood (2019) 134 (Supplement_1): 1981.

https://doi.org/10.1182/blood-2019-125828

Published: 2019

Journal Articles

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Lymphoblastic Leukemia: ALWP of the EBMT Study

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Emanuele Angelucci, MD, Johanna Tischer, MD, Mutlu Arat, MD, Fabio Ciceri, MD, Zafer Gülbas, MD, Hakan Ozdogu, MD, Simona Sica, MD, Jose L. Diez-Martin, MD PhD, Yener Koc, MD, Jane Apperley, MB, ChB, MD, Gerard Socie, MD PhD, Sebastian Giebel, MD PhD, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 320.

https://doi.org/10.1182/blood-2019-122258

Published: 2019

Journal Articles

Identification of New Polymorphisms in Genes of the Immune System Associated with Acute Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell Transplantation

Paula Muñiz Sevilla, Carolina Martínez-Laperche, Mi Kwon, MD, Rebeca Bailén, MD, Nieves Dorado, MD, Laura Solán, MD, Diego Carbonell, Mr, Julia Suárez González, María Chicano Lavilla, PhD, Cristina Andres, Jose Maria Bellon, Juan Carlos Triviño, Javier Anguita, MD PhD, Jose L. Diez-Martin, MD PhD, Ismael Buño, PhD

Blood (2019) 134 (Supplement_1): 3286.

https://doi.org/10.1182/blood-2019-126010

Published: 2019

Journal Articles

Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease: A Study on Behalf of the Acute Leukemia Working Party of EBMT

Avichai Shimoni, MD, Myriam Labopin, MD, Emanuele Angelucci, MD, Didier Blaise, Fabio Ciceri, MD, Yener Koc, Zafer Gülbas, Jose L. Diez-Martin, MD PhD, Benedetto Bruno, Luca Castagna, MD, Massimo Martino, Montserrat Rovira, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 4586.

https://doi.org/10.1182/blood-2018-99-110609

Published: 2018

Journal Articles

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Blood (2018) 132 (Supplement 1): 486.

https://doi.org/10.1182/blood-2018-99-114033

Published: 2018

Journal Articles

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

Blood (2018) 132 (Supplement 1): 484.

https://doi.org/10.1182/blood-2018-99-111674

Published: 2018

NARROW

Acquired Factor XIII Deficiency Is Associated with High Morbidity and Mortality in Critically Ill Patients

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies

Dynamics and Management of CAR-T Cells Associated Cytopenias: A Single-Center Experience

Post-Transplant Cyclophosphamide after HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of Geth-TC

Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) ¿Is the Threshold of 20% Bone Marrow Blasts Reproducible?

Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience from the Spanish Group of Hematopoietic Transplant (GETH-TC)

Cell-Free DNA Dynamic Concentration, CRP and LDH Pre-Infusion Are Predictors of Early Progression after CAR T-Cell Therapy in DLBCL Patients

Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma in the Real World Setting in Spain

Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

Association of Gene Polymorphisms in Cyclophosphamide Metabolism Pathway with Complications after Haploidentical Hematopoietic Stem Cell Transplantation

Impact of Minimal Residual Disease and Chimerism Monitoring at Different Timepoints after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Very Severe Veno-Occlusive Disease after Unmanipulated Haploidentical HSCT with Post-Transplant Cyclophosphamide

Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Lymphoblastic Leukemia: ALWP of the EBMT Study

Identification of New Polymorphisms in Genes of the Immune System Associated with Acute Graft Versus Host Disease after Identical HLA-Allogeneic Stem-Cell Transplantation

Graft-Versus-Leukemia Effect after Haplo-Identical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with AML- No Association with Graft-Versus-Host Disease: A Study on Behalf of the Acute Leukemia Working Party of EBMT

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Influence of Donor Type, Stem Cell Source and Conditioning Regimen on Transplant Outcomes after Haploidentical Transplant with Post Transplant Cyclophosphamide for Lymphoma: A Report of the EBMT Lymphoma Working Party

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only